Newfeed

WASHINGTON, Jan. 25, 2024 /PRNewswire/ — Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced the publication of an article titled “The Efficacy of Tradipitant in Patients with Diabetic and Idiopathic Gastroparesis in Phase III Randomized Placebo-Controlled Clinical Trial&#8

Magazine made for you.

Featured:

No posts were found for provided query parameters.

Elsewhere: